Endothelin-1 and brain natriuretic peptide plasma levels decrease after aortic surgery

Journal of Heart Valve Disease

Volumn 19, Issue 6, 2010, Pages 724-730

  Raffa, Giuseppe M ^a   Jackson, Veronica ^b   Liska, Jan ^b   Eriksson, Maria J ^b   Caidahl, Kenneth ^b   Eriksson, Per ^b   Franco Cereceda, Anders ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1;

ADULT; AGED; AORTA ANEURYSM; AORTA SURGERY; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL PATIENT; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DOWN-REGULATION; ENDOTHELIN-1; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE VOLUME; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79551489045     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 2005;95:8B-13B
2. Ray S. Natriuretic peptides in heart valve disease. Heart 2006;92:1194-1197 (Pubitemid 44298853)
3. Jensen LW, Bagger JP, Pedersen EB. Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease. Blood Press 1996;5:292-299
4. Flondell-Site D, Lindblad B, Gottsater A. High levels of endothelin (ET)-1 and aneurysm diameter independently predict growth of stable abdominal aortic aneurysms. Angiology 2010;61:324-328
5. Wagner A, Domanovits H, Holzer M, et al. Plasma endothelin in patients with acute aortic disease. Resuscitation 2002;53:71-76 (Pubitemid 34310212)
6. Konstam MA, Udelson JE, Anand IS, Cohn JN. Ventricular remodelling in heart failure: A credible surrogate endpoint. J Card Fail 2003;9:350-353
7. Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007;76:8-18
8. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985;248:C550-C556 (Pubitemid 15018364)
9. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81
10. de Lemos JA, McGuire DK, Dranzner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-322
11. Moe GW, Rouleau JL, Nguyen QT, Cernacek P, Stewart DJ. Role of endothelins in congestive heart failure. Can J Physiol Pharmacol 2003;81:588-597 (Pubitemid 36840925)
12. Serneri GG, Modesti PA, Boddi M, et al. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res 1999;85:57-67
13. Stanek B, Frey B, Hulsmann M, et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001;38:436-442
14. Pousset F, Isnard R, Lechat P, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997;18:254-258
15. Ueno M, Miyauchi T, Sakai S, Kobayashi T, Goto K, Yamaguchi I. Effects of physiological or pathological pressure load in vivo on myocardial expression of ET-1 and receptors. Am J Physiol 1999;277: R1321-R1330
16. Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993;73:887-897 (Pubitemid 23306133)
17. Yorikane R, Sakai S, Miyauchi T, Sakurai T, Sugishita T, Goto K. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett 1993;332:31-34
18. Ramirez-Gil JF, Drobinski G, Carayon A, et al. Neurohormonal profile in aortic valve stenosis. Arch Mal Coeur Vaiss 1993;86:100-107
19. Bergler-Klein J, Klaar U, Heger M, et al. Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure. Int J Cardiol 2006;113:174-180
20. Hrudova J, Linhart A, Vondracek V, et al. Humoral profile of patients with severe aortic stenosis. Cas Lek Cesk 2000;139:74-78
21. Fukuda N, Shinohara H, Sakabe K, et al. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. J Heart Valve Dis 2003;12:333-340
22. Qi W, Mathisen P, Kjekhus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001;142:725-732 (Pubitemid 32900502)
23. Talwar S, Downie PF, Squire IB, et al. Plasma N-terminal pro BNP and cardiotropin-1 are elevated in aortic stenosis. Eur J Heart Fail 2001;3:15-19
24. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pvro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94: 740-745
25. Gerber IL, Stewart RAH, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-1890
26. Prasad N, Bridges A, Lang CC, et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J 1997;133:477-479 (Pubitemid 27188474)
27. Vanderheyden M, Goethals M, Verstreken S, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004;44:2349-2354
28. Qi W, Mathisen P, Kjekhus J, et al. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol 2002;25:174-180
29. Gerber IL, Stewart RAH, French JK, et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol 2003;92:755-758
30. Eimer MJ, Ekery DL, Rigolin VH, et al. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol 2004;94: 676-678
31. Gabriel RS, Kerr AJ, Sharma V, Zeng IS, Stewart RA. B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation. Heart 2008;94:897-902
32. Toole JM, Ikonomidis JS, Szeto WY, et al. Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics. J Thorac Cardiovasc Surg 2010;139:646-654
33. Peltonen T, Taskinen P, Näpänkangas J, et al. Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis. Eur Heart J 2009;30:242-249